Nutrien (NTR) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changing earn ...

智通财经APP获悉，在黄金、白银等硬商品行情持续吸引市场目光之际，软商品板块正悄悄积累动能， 逐步走进"舞台"中央。谷物、畜牧、乳制品等农业相关品种近期整体走强，也带动覆盖农业全产业链获 得关注。 农产品加工与贸易板块中，Archer Daniels Midland(ADM.US)年内已上涨约17%，股息率接近3%。股价 逼近52周高点，并完成关键65美元关口的向上突破，周线图呈现"倒头肩底"形态。同行邦吉(BG.US)同 期上涨约25%，形成良好的同业验证。若后续有效站稳200周均线，上行空间或进一步打开，年内目标 被看至90美元。 防御型食品板块方面，美国达尔令国际(DAR.US)过去三个月累计上涨约23%，五周连涨，周线50周均 线多年后首次拐头向上。股价近期突破40美元关键阻力位，若守住37美元上方，中期或指向55美元。 在个股层面，部分农业相关股票已率先走强并进入技术性整固阶段。此前两周累计上涨近20%的 Nutrien(NTR.US)，便被视为强势标的之一。与此同时，市场开始将目光投向仍具上行潜力的品种。 化肥与基础材料板块方面，CF工业控股(CF.US)年初至今涨幅已超过18%，并录得四周连涨， ...

About Nutrien Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals. SASKATOON, Saskatchewan--(BUSINESS ...

Core Viewpoint - Nutrien's shares experienced a significant increase of 7.9% to $66.2, driven by an upgrade from Morgan Stanley and a higher trading volume [1] Group 1: Stock Performance - Nutrien's stock rose 7.9% in the last trading session, contrasting with a 0.8% loss over the previous four weeks [1] - The stock's price target was raised by Morgan Stanley from $70 to $77 following the upgrade to "Overweight" from "Equal-Weight" [1] Group 2: Earnings Expectations - Nutrien is expected to report quarterly earnings of $0.87 per share, reflecting a year-over-year increase of 180.7% [2] - Projected revenues for the upcoming report are $5.24 billion, which is a 3.2% increase compared to the same quarter last year [2] Group 3: Earnings Estimate Trends - The consensus EPS estimate for Nutrien has remained unchanged over the last 30 days, indicating a potential lack of momentum in stock price movement without earnings estimate revisions [3] - Monitoring Nutrien's performance is advised to determine if the recent stock price increase can sustain itself [3] Group 4: Industry Context - Nutrien is part of the Zacks Fertilizers industry, which includes CF Industries, another company that saw a 2.6% increase in its stock price [4] - CF Industries has a consensus EPS estimate of $2.55, representing a year-over-year change of 34.9% [5]

Core Insights - U.S. stocks experienced a decline, with the Nasdaq Composite dropping over 200 points on Wednesday [1] - TG Therapeutics Inc reported preliminary total global revenue for fiscal year 2025 of approximately $616 million, leading to a significant increase in its stock price [2] Company Performance - TG Therapeutics reported U.S. net product revenue for BRIUMVI of approximately $182 million for Q4 and $594 million for the full year, with these figures being unaudited [2] - TG Therapeutics shares surged by 11.6% to $31.10 following the revenue announcement [2] Other Notable Stock Movements - Rich Sparkle Holdings Ltd shares increased by 13.5% to $95.31 [3] - Cerus Corp gained 12.7% to $2.84 [3] - Clover Health Investments Corp saw an 11.2% rise to $2.82, driven by year-over-year membership growth in its Medicare Advantage PPO plans [3] - Highpeak Energy Inc shares rose by 8.3% to $5.07 [3] - Nutrien Ltd gained 7% to $65.62 after an upgrade from Morgan Stanley analyst Vincent Sinisi, with a price target increase from $70 to $77 [3]

Nutrien Ltd (NYSE:NTR) is one of the best fertilizer stocks to invest in. On December 18, analysts at Mizuho raised Nutrien Ltd’s (NYSE:NTR) price target to $65 from $61 while reiterating a Neutral rating. The stock has rallied about 36% in 2025. Nutrien Ltd. (NTR) Delivers Portfolio Simplification and Growth Focus After Strong 2025 Rally Following the impressive run, Nutrien Ltd also completed the sale of its 50% equity position in Argentina-based nitrogen producer Profertil S.A. to Adecoagro S.A. and A ...

Group 1: Company Developments - Nutrien Ltd. has streamlined its portfolio by selling its 50% equity stake in Argentina-based nitrogen producer Profertil S.A. for approximately $600 million in pre-tax proceeds [3] - The company has generated roughly $900 million in gross proceeds from asset sales since Q4 2024, indicating a broader divestment strategy to enhance focus and strengthen its balance sheet [4] - Nutrien's President and CEO, Ken Seitz, emphasized that the sale of Profertil is part of efforts to simplify the portfolio, improve earnings quality, and enhance cash conversion [4] Group 2: Market Outlook - Mizuho raised its price target on Nutrien to $65 from $61 while maintaining a Neutral rating, reflecting ongoing pressures in the chemicals, agriculture, and packaging sector [2] - The analyst noted that higher export volumes from China are impacting basic chemical markets, and a weak start to the March quarter is anticipated following a weak December quarter for many companies in the sector [2] Group 3: Business Operations - Nutrien operates as a global supplier of essential crop nutrients, producing and distributing potash, nitrogen, and phosphate [4] - The company supports farmers through its retail platform, Nutrien Ag Solutions, which offers products, services, and agronomic expertise across key agricultural regions [4]

Industry Overview - Fertilizer stocks, including Mosaic, CF Industries, and Nutrien, are highlighted as key investments due to their significant trading volume recently [2] - These stocks are linked to agricultural nutrients such as nitrogen, phosphate, and potash, which are essential for enhancing crop yields [2] - The performance of fertilizer companies is influenced by various factors including crop prices, planting demand, feedstock and energy costs, weather conditions, trade policies, and environmental regulations [2] Company Profiles - **Mosaic Company**: Engages in the production and marketing of concentrated phosphate and potash crop nutrients, operating through three segments: Phosphates, Potash, and Mosaic Fertilizantes [3] - **CF Industries**: Focuses on manufacturing and selling hydrogen and nitrogen products for various applications, operating through segments such as Ammonia, Granular Urea, UAN, AN, and others [4] - **Nutrien Ltd.**: Provides crop inputs and services across four segments: Retail, Potash, Nitrogen, and Phosphate, distributing crop nutrients, protection products, seeds, and merchandise [4]

Industry Overview - The fertilizer industry experienced a rebound in 2025 after a challenging 2024 characterized by significant price declines due to oversupply and weak demand [1][11] - Improved fertilizer prices in 2025, particularly for phosphate, potash, and nitrogen, have contributed to revenue and margin expansion for companies in the sector [4][10] - Despite the recovery, the industry still faces challenges such as elevated raw material costs and potential reductions in fertilizer application rates by farmers due to affordability issues [2][5][7] Market Dynamics - Fertilizer prices dropped sharply in 2024 due to oversupply, weak global demand, and normalization of supply chains, leading to a market glut [3] - The increase in fertilizer prices in 2025 is attributed to strong agricultural demand, China's export restrictions, U.S. tariffs, and higher input costs [4][10] - The U.S. Department of Agriculture projects a 40.7% increase in net farm income to $179.8 billion in 2025, although this is a slight decline from earlier projections [6] Company Insights - Nutrien Ltd. (NTR) is benefiting from higher demand for crop nutrients, operational efficiency, and strategic acquisitions, with an expected earnings growth of 32.6% for 2025 [13][14] - Yara International ASA (YARIY) is positioned well due to favorable nitrogen demand and cost reduction initiatives, with an expected earnings growth rate of 150.6% for 2025 [15][16] - Intrepid Potash, Inc. (IPI) is experiencing strong demand for its products, with a projected earnings growth rate of 506.7% for 2025, driven by healthy farmer economics [18][19]

Core Viewpoint - Shares of Mosaic, Nutrien, CF Industries, and Intrepid Potash are experiencing downward pressure following the U.S. decision to lift sanctions on Belarusian potash fertilizers, indicating potential market shifts in the fertilizer industry [1]. Group 1: Market Reaction - Mosaic's shares are down 3%, Nutrien's by 4%, CF Industries by 1.5%, and Intrepid Potash by 1% in response to the news [1]. Group 2: Regulatory Changes - The U.S. has announced the immediate removal of sanctions on Belarusian potash fertilizers, as stated by special envoy John Coale [1]. - This decision is part of a broader effort to normalize relations between the U.S. and Belarus, potentially leading to further easing of restrictions [1].